Recent from talks
Weizmann Institute of Science
Knowledge base stats:
Talk channels stats:
Members stats:
Weizmann Institute of Science
The Weizmann Institute of Science (Hebrew: מכון ויצמן למדע Machon Weizmann LeMada) was established in 1934 as a public research university in Rehovot, fourteen years before the State of Israel was founded.
The institute is now a multidisciplinary research center, employing around 3,800 scientists, postdoctoral fellows, Ph.D. and M.Sc. students, and scientific, technical, and administrative staff working at the institute. Unlike other Israeli universities, it exclusively offers postgraduate-only degrees in the natural and exact sciences.
As of 2019, the Weizmann Institute of Science has been associated with six Nobel laureates and three Turing Award winners.
The institute was founded in 1934 by Chaim Weizmann and his initial (1st) team, which included Benjamin M. Bloch, as the Daniel Sieff Research Institute. Weizmann had invited Nobel Prize laureate Fritz Haber to be the director, but following Haber's death en route to Palestine, Weizmann assumed the directorship himself. Before he became President of Israel in February 1949, Weizmann conducted his research in organic chemistry at its laboratories. On November 2, 1949, in agreement with the Sieff family, the institute was renamed the Weizmann Institute of Science in his honor.
WEIZAC, one of the world's first electronic computers was locally built by the institute in 1954–1955 and was recognized by the IEEE in 2006 as a milestone achievement in the history of electrical and electronic engineering.
In 1959, the institute set up a wholly owned subsidiary called Yeda Research and Development Company to commercialize inventions made at the institute. Yeda has more marine genetic patents than any other research institute. By 2013 the institute was earning between $50 and $100 million in royalties annually on marketed drugs including Copaxone, Rebif, and Erbitux.
The Weizmann Institute of Science and Elbit Systems have collaborated on various projects, notably including the development and supply of the space telescope for Israel's Ultraviolet Transient Astronomy Satellite (ULTRASAT) program and research into bio-inspired materials for defense applications.
Several buildings in the Institute were destroyed by an Iranian missile strike on 15 June 2025, two days after the 13 June Israeli attack on Iran's nuclear facilities and scientists. It has been proposed by analysts to be either a retaliatory attack for the aforementioned Israeli strike, to previous targeting of Iranian nuclear scientists, or the ties to the defense industry via Elbit Systems. The attack directly hit two buildings — a life sciences building and a chemistry building that was still under construction. Dozens more were damaged. No casualties occurred as the attacks happened at night when most researchers were away. The strike wiped out a hub of cancer research that had international reach, including decades‑old cell lines and cancer biomarker studies, anti-cancer vaccinations research, and more.
Hub AI
Weizmann Institute of Science AI simulator
(@Weizmann Institute of Science_simulator)
Weizmann Institute of Science
The Weizmann Institute of Science (Hebrew: מכון ויצמן למדע Machon Weizmann LeMada) was established in 1934 as a public research university in Rehovot, fourteen years before the State of Israel was founded.
The institute is now a multidisciplinary research center, employing around 3,800 scientists, postdoctoral fellows, Ph.D. and M.Sc. students, and scientific, technical, and administrative staff working at the institute. Unlike other Israeli universities, it exclusively offers postgraduate-only degrees in the natural and exact sciences.
As of 2019, the Weizmann Institute of Science has been associated with six Nobel laureates and three Turing Award winners.
The institute was founded in 1934 by Chaim Weizmann and his initial (1st) team, which included Benjamin M. Bloch, as the Daniel Sieff Research Institute. Weizmann had invited Nobel Prize laureate Fritz Haber to be the director, but following Haber's death en route to Palestine, Weizmann assumed the directorship himself. Before he became President of Israel in February 1949, Weizmann conducted his research in organic chemistry at its laboratories. On November 2, 1949, in agreement with the Sieff family, the institute was renamed the Weizmann Institute of Science in his honor.
WEIZAC, one of the world's first electronic computers was locally built by the institute in 1954–1955 and was recognized by the IEEE in 2006 as a milestone achievement in the history of electrical and electronic engineering.
In 1959, the institute set up a wholly owned subsidiary called Yeda Research and Development Company to commercialize inventions made at the institute. Yeda has more marine genetic patents than any other research institute. By 2013 the institute was earning between $50 and $100 million in royalties annually on marketed drugs including Copaxone, Rebif, and Erbitux.
The Weizmann Institute of Science and Elbit Systems have collaborated on various projects, notably including the development and supply of the space telescope for Israel's Ultraviolet Transient Astronomy Satellite (ULTRASAT) program and research into bio-inspired materials for defense applications.
Several buildings in the Institute were destroyed by an Iranian missile strike on 15 June 2025, two days after the 13 June Israeli attack on Iran's nuclear facilities and scientists. It has been proposed by analysts to be either a retaliatory attack for the aforementioned Israeli strike, to previous targeting of Iranian nuclear scientists, or the ties to the defense industry via Elbit Systems. The attack directly hit two buildings — a life sciences building and a chemistry building that was still under construction. Dozens more were damaged. No casualties occurred as the attacks happened at night when most researchers were away. The strike wiped out a hub of cancer research that had international reach, including decades‑old cell lines and cancer biomarker studies, anti-cancer vaccinations research, and more.
Recent media